Skip to main content
Erschienen in: Strahlentherapie und Onkologie 8/2017

22.02.2017 | Original Article

External-beam radiation therapy combined with limb-sparing surgery in elderly patients (>70 years) with primary soft tissue sarcomas of the extremities

A retrospective analysis

verfasst von: Dr. med. univ. Claudia Andrä, M.D., Dr. med. Alexander Klein, M.D., Prof. Dr. med. Hans Roland Dürr, M.D., Dr. med. Josefine Rauch, M.D., Priv.-Doz. Dr. med. Lars Hartwin Lindner, M.D., Prof. Dr. med. Thomas Knoesel, M.D., Prof. Dr. med. Martin Angele, M.D., Prof. Dr. med. Andrea Baur-Melnyk, M.D., Prof. Dr. med. Claus Belka, M.D., Priv.-Doz. Dr. med. Falk Roeder, M.D.

Erschienen in: Strahlentherapie und Onkologie | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To report our experience with EBRT combined with limb-sparing surgery in elderly patients (>70 years) with primary extremity soft tissue sarcomas (STS).

Methods

Retrospectively analyzed were 35 patients (m:f 18:17, median 78 years) who all presented in primary situation without nodal/distant metastases (Charlson score 0/1 in 18 patients; ≥2 in 17 patients). Median tumor size was 10 cm, mainly located in lower limb (83%). Stage at presentation (UICC7th) was Ib:3%, 2a:20%, 2b:20%, and 3:57%. Most lesions were high grade (97%), predominantly leiomyosarcoma (26%) and undifferentiated pleomorphic/malignant fibrous histiocytoma (23%). Limb-sparing surgery was preceded (median 50 Gy) or followed (median 66 Gy) by EBRT.

Results

Median follow-up was 37 months (range 1–128 months). Margins were free in 26 patients (74%) and microscopically positive in 9 (26%). Actuarial 3‑ and 5‑year local control rates were 88 and 81% (4 local recurrences). Corresponding rates for distant control, disease-specific survival, and overall survival were 57/52%, 76/60%, and 72/41%. The 30-day mortality was 0%. Severe postoperative complications were scored in 8 patients (23%). Severe acute radiation-related toxicity was observed in 2 patients (6%). Patients with Charlson score ≥2 had a significantly increased risk for severe postoperative complications and acute radiation-related side effects. Severe late toxicities were found in 7 patients (20%), including fractures in 3 (8.6%). Final limb preservation rate was 97%.

Conclusion

Combination of EBRT and limb-sparing surgery is feasible in elderly patients with acceptable toxicities and encouraging but slightly inferior outcome compared to younger patients. Comorbidity correlated with postoperative complications and acute toxicities. Late fracture risk seems slightly increased.
Literatur
1.
Zurück zum Zitat Zhao RP, Yu XL, Zhang Z et al (2016) The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery. Radiat Oncol 11:25CrossRefPubMedPubMedCentral Zhao RP, Yu XL, Zhang Z et al (2016) The efficacy of postoperative radiotherapy in localized primary soft tissue sarcoma treated with conservative surgery. Radiat Oncol 11:25CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Andrä C, Rauch J, Li M et al (2015) Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck. Radiat Oncol 10:140CrossRefPubMedPubMedCentral Andrä C, Rauch J, Li M et al (2015) Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck. Radiat Oncol 10:140CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Jensen AD, Uhl M, Chaudhri N et al (2015) Carbon ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheath tumors: acute toxicity and preliminary outcome. Radiat Oncol 10:109CrossRefPubMedPubMedCentral Jensen AD, Uhl M, Chaudhri N et al (2015) Carbon ion irradiation in the treatment of grossly incomplete or unresectable malignant peripheral nerve sheath tumors: acute toxicity and preliminary outcome. Radiat Oncol 10:109CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Calvo FA, Sole CV, Polo A et al (2014) Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity. Strahlenther Onkol 190:891–898CrossRefPubMed Calvo FA, Sole CV, Polo A et al (2014) Limb-sparing management with surgical resection, external-beam and intraoperative electron-beam radiation therapy boost for patients with primary soft tissue sarcoma of the extremity. Strahlenther Onkol 190:891–898CrossRefPubMed
5.
Zurück zum Zitat Hata M, Wada H, Ogino I et al (2014) Radiation therapy for angiosarcoma of the scalp. Strahlenther Onkol 190:899–904CrossRefPubMed Hata M, Wada H, Ogino I et al (2014) Radiation therapy for angiosarcoma of the scalp. Strahlenther Onkol 190:899–904CrossRefPubMed
6.
Zurück zum Zitat Yang JC, Chang E, Baker R et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197–203CrossRefPubMed Yang JC, Chang E, Baker R et al (1998) Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol 16:197–203CrossRefPubMed
7.
Zurück zum Zitat Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859–868CrossRefPubMed Pisters PW, Harrison LB, Leung DH et al (1996) Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. J Clin Oncol 14:859–868CrossRefPubMed
8.
Zurück zum Zitat Hoven-Gondrie ML, Bastiaannet E, Ho VK et al (2016) Worse survival in elderly patients with extremity soft-tissue sarcoma. Ann Surg Oncol 23:2577–2585CrossRefPubMedPubMedCentral Hoven-Gondrie ML, Bastiaannet E, Ho VK et al (2016) Worse survival in elderly patients with extremity soft-tissue sarcoma. Ann Surg Oncol 23:2577–2585CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061–2067CrossRefPubMed Hutchins LF, Unger JM, Crowley JJ et al (1999) Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 341:2061–2067CrossRefPubMed
10.
Zurück zum Zitat Semrau S, Zettl H, Hildebrandt G et al (2014) Older patients with inoperable non-small cell lung cancer: long-term survival after concurrent chemoradiotherapy. Strahlenther Onkol 190:1125–1132CrossRefPubMed Semrau S, Zettl H, Hildebrandt G et al (2014) Older patients with inoperable non-small cell lung cancer: long-term survival after concurrent chemoradiotherapy. Strahlenther Onkol 190:1125–1132CrossRefPubMed
11.
Zurück zum Zitat Brown ML, Glanzmann C, Huber G et al (2016) IMRT/VMAT for malignancies in the head-and-neck region: outcome in patients aged 80. Strahlenther Onkol 192:526–536CrossRefPubMedPubMedCentral Brown ML, Glanzmann C, Huber G et al (2016) IMRT/VMAT for malignancies in the head-and-neck region: outcome in patients aged 80. Strahlenther Onkol 192:526–536CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Fentiman IS, Tirelli U, Monfardini S et al (1990) Cancer in the elderly:why so badly treated? Lancet 335:1020–1022CrossRefPubMed Fentiman IS, Tirelli U, Monfardini S et al (1990) Cancer in the elderly:why so badly treated? Lancet 335:1020–1022CrossRefPubMed
13.
Zurück zum Zitat Balducci L (2000) Geriatric oncology: challenges fort he new century. Eur J Cancer 36:1741–1754CrossRefPubMed Balducci L (2000) Geriatric oncology: challenges fort he new century. Eur J Cancer 36:1741–1754CrossRefPubMed
14.
Zurück zum Zitat Biau DJ, Ferguson PC, Turcotte RE et al (2011) Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol 29:4029–4035CrossRefPubMed Biau DJ, Ferguson PC, Turcotte RE et al (2011) Adverse effect of older age on the recurrence of soft tissue sarcoma of the extremities and trunk. J Clin Oncol 29:4029–4035CrossRefPubMed
15.
Zurück zum Zitat Al-Refaie WB, Habermann EB, Dudeja V et al (2010) Extremity soft tissue sarcoma care in the elderly: insights into the generalizability of NCI Cancer Trials. Ann Surg Oncol 17:1732–1738CrossRefPubMed Al-Refaie WB, Habermann EB, Dudeja V et al (2010) Extremity soft tissue sarcoma care in the elderly: insights into the generalizability of NCI Cancer Trials. Ann Surg Oncol 17:1732–1738CrossRefPubMed
16.
Zurück zum Zitat Kemeny M (2000) Cancer surgery in the older cancer patient. Hematol Oncol Clin North Am 14:169–192CrossRefPubMed Kemeny M (2000) Cancer surgery in the older cancer patient. Hematol Oncol Clin North Am 14:169–192CrossRefPubMed
17.
Zurück zum Zitat Zachariah B, Balducci L (2000) Radiation therapy of the older cancer patient. Hematol Oncol Clin North Am 14:13–168CrossRef Zachariah B, Balducci L (2000) Radiation therapy of the older cancer patient. Hematol Oncol Clin North Am 14:13–168CrossRef
18.
Zurück zum Zitat Nijhuis PH, Schaapveld M, Otter R et al (1999) Epidemiological aspects of soft tissue sarcomas (STS) – consequences for the design of clinical STS trials. Eur J Cancer 35:1705–1710CrossRefPubMed Nijhuis PH, Schaapveld M, Otter R et al (1999) Epidemiological aspects of soft tissue sarcomas (STS) – consequences for the design of clinical STS trials. Eur J Cancer 35:1705–1710CrossRefPubMed
19.
Zurück zum Zitat Lahat G, Dhuka R, Lahat S et al (2009) Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol 16:2579–2586CrossRefPubMed Lahat G, Dhuka R, Lahat S et al (2009) Complete soft tissue sarcoma resection is a viable treatment option for select elderly patients. Ann Surg Oncol 16:2579–2586CrossRefPubMed
20.
Zurück zum Zitat Boden R, Clark M, Neuhaus SJ et al (2006) Surgical management of soft tissue sarcoma in patients over 80 years. Eur J Surg Oncol 32:1154–1158CrossRefPubMed Boden R, Clark M, Neuhaus SJ et al (2006) Surgical management of soft tissue sarcoma in patients over 80 years. Eur J Surg Oncol 32:1154–1158CrossRefPubMed
21.
Zurück zum Zitat Issels RD, Lindner LH, Verweij J et al (2010) Neoadjuvant chemotherapy alone or with regional hyperthermia for localized high-risk soft-tissue sarcoma: a randomized phase 3 multicentre study. Lancet Oncol 11:561–570CrossRefPubMedPubMedCentral Issels RD, Lindner LH, Verweij J et al (2010) Neoadjuvant chemotherapy alone or with regional hyperthermia for localized high-risk soft-tissue sarcoma: a randomized phase 3 multicentre study. Lancet Oncol 11:561–570CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Folkert MR, Singer S, Brennan MF et al (2014) Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol 32:3236–3241CrossRefPubMedPubMedCentral Folkert MR, Singer S, Brennan MF et al (2014) Comparison of local recurrence with conventional and intensity-modulated radiation therapy for primary soft-tissue sarcomas of the extremity. J Clin Oncol 32:3236–3241CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Alektiar KM, Brennan MF, Healey JH et al (2008) Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol 26:3440–3444CrossRefPubMed Alektiar KM, Brennan MF, Healey JH et al (2008) Impact of intensity-modulated radiation therapy on local control in primary soft-tissue sarcoma of the extremity. J Clin Oncol 26:3440–3444CrossRefPubMed
24.
Zurück zum Zitat Gronchi A, Casali PG, Mariani L et al (2005) Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol 23:96–104CrossRefPubMed Gronchi A, Casali PG, Mariani L et al (2005) Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol 23:96–104CrossRefPubMed
25.
Zurück zum Zitat Eilber FC, Rosen G, Nelson SD et al (2003) High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 237:218–226PubMedPubMedCentral Eilber FC, Rosen G, Nelson SD et al (2003) High-grade extremity soft tissue sarcomas: factors predictive of local recurrence and its effect on morbidity and mortality. Ann Surg 237:218–226PubMedPubMedCentral
26.
Zurück zum Zitat Roeder F, Lehner B, Saleh-Ebrahimi L et al (2016) Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases. Radiother Oncol 119:22–29CrossRefPubMed Roeder F, Lehner B, Saleh-Ebrahimi L et al (2016) Intraoperative electron radiation therapy combined with external beam radiation therapy and limb sparing surgery in extremity soft tissue sarcoma: a retrospective single center analysis of 183 cases. Radiother Oncol 119:22–29CrossRefPubMed
27.
Zurück zum Zitat Roeder F, Lehner B, Schmitt T et al (2014) Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC Cancer 14:350CrossRefPubMedPubMedCentral Roeder F, Lehner B, Schmitt T et al (2014) Excellent local control with IOERT and postoperative EBRT in high grade extremity sarcoma: results from a subgroup analysis of a prospective trial. BMC Cancer 14:350CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235–2241CrossRefPubMed O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359:2235–2241CrossRefPubMed
29.
Zurück zum Zitat Weitz J, Antonescu CR, Brennan MF (2003) Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol 21:2719–2725CrossRefPubMed Weitz J, Antonescu CR, Brennan MF (2003) Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J Clin Oncol 21:2719–2725CrossRefPubMed
30.
Zurück zum Zitat Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97:2530–2543CrossRefPubMed Zagars GK, Ballo MT, Pisters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer 97:2530–2543CrossRefPubMed
31.
Zurück zum Zitat Buchner M, Bernd L, Zahlten-Hinguranage A et al (2004) Primary malignant tumours of bone and soft tissue in the elderly. Eur J Surg Oncol 30:877–883CrossRefPubMed Buchner M, Bernd L, Zahlten-Hinguranage A et al (2004) Primary malignant tumours of bone and soft tissue in the elderly. Eur J Surg Oncol 30:877–883CrossRefPubMed
32.
Zurück zum Zitat Gortzak Y, Lockwood GA, Mahendra A et al (2010) Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh. Cancer 116:1553–1559CrossRefPubMed Gortzak Y, Lockwood GA, Mahendra A et al (2010) Prediction of pathologic fracture risk of the femur after combined modality treatment of soft tissue sarcoma of the thigh. Cancer 116:1553–1559CrossRefPubMed
33.
Zurück zum Zitat Davis AM, Osullivan B, Turcotte R et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48–53CrossRefPubMed Davis AM, Osullivan B, Turcotte R et al (2005) Late radiation morbidity following randomization to preoperative versus postoperative radiotherapy in extremity soft tissue sarcoma. Radiother Oncol 75:48–53CrossRefPubMed
34.
Zurück zum Zitat Cannon CP, Ballo MT, Zagars GK et al (2006) Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455–2461CrossRefPubMed Cannon CP, Ballo MT, Zagars GK et al (2006) Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 107:2455–2461CrossRefPubMed
35.
Zurück zum Zitat Holt GE, Griffin AM, Pintilie M (2007) Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am 87:315–319CrossRef Holt GE, Griffin AM, Pintilie M (2007) Fractures following radiotherapy and limb-salvage surgery for lower extremity soft-tissue sarcomas. A comparison of high-dose and low-dose radiotherapy. J Bone Joint Surg Am 87:315–319CrossRef
36.
Zurück zum Zitat Hong L, Alektiar KM, Hunt M et al (2004) Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys 59:752–759CrossRefPubMed Hong L, Alektiar KM, Hunt M et al (2004) Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh. Int J Radiat Oncol Biol Phys 59:752–759CrossRefPubMed
Metadaten
Titel
External-beam radiation therapy combined with limb-sparing surgery in elderly patients (>70 years) with primary soft tissue sarcomas of the extremities
A retrospective analysis
verfasst von
Dr. med. univ. Claudia Andrä, M.D.
Dr. med. Alexander Klein, M.D.
Prof. Dr. med. Hans Roland Dürr, M.D.
Dr. med. Josefine Rauch, M.D.
Priv.-Doz. Dr. med. Lars Hartwin Lindner, M.D.
Prof. Dr. med. Thomas Knoesel, M.D.
Prof. Dr. med. Martin Angele, M.D.
Prof. Dr. med. Andrea Baur-Melnyk, M.D.
Prof. Dr. med. Claus Belka, M.D.
Priv.-Doz. Dr. med. Falk Roeder, M.D.
Publikationsdatum
22.02.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Strahlentherapie und Onkologie / Ausgabe 8/2017
Print ISSN: 0179-7158
Elektronische ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-017-1109-x

Weitere Artikel der Ausgabe 8/2017

Strahlentherapie und Onkologie 8/2017 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.